Construction and application of thyroid cancer auxiliary diagnosis system based on multi group science fusion

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300075958

Enrollment

Unknown

Registered

2023-09-20

Start date

2022-10-10

Completion date

Unknown

Last updated

2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid carcinoma

Interventions

Thyroid Cancer group (Pre operative/Post operative):None

Normal group:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Normal volunteers: (1) People aged 20-50 years without any cancer, digestive and endocrine related diseases; (2) Informed consent, volunteer participation and sign the informed consent form. Thyroid Cancer volunteers: (1) Primary papillary thyroid carcinoma was first diagnosed and pathologically determined; (2) None of the volunteers had received any treatment before admission. (3) Patients give informed consent, volunteer and sign the informed consent form

Exclusion criteria

Exclusion criteria: (1) The volunteers had other cancers other than primary thyroid cancer; (2) The volunteers have a history of alcohol or narcotic abuse, drug use, psychiatric history (such as schizophrenia, obsessive-compulsive disorder, depression), confrontational personality, bad motivation, paranoia, or other emotional or intellectual problems that may affect the informed validity of participation in the study; (3) The volunteers had other endocrine related diseases.

Design outcomes

Primary

Measure	Time frame
16S rDNA;Metabolomics;	—

Countries

China

Contacts

Public ContactWenyi Qin

Affiliated Hospital of Guangdong Medical University

181039376@qq.com+86 138 2482 1777

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026